Clinical Trial Update: CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

Clinical trial update noting completion of the Phase 1 study CLBS201 in patients with chronic kidney disease and type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLBS201

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: Chronic Kidney Diseases | Phase 1 | Status: COMPLETED